Failure of Dual Antimicrobial Therapy for Gonorrhea Reported

Share this content:
Failure of Dual Antimicrobial Therapy for Gonorrhea Reported
Failure of Dual Antimicrobial Therapy for Gonorrhea Reported

THURSDAY, June 23, 2016 (HealthDay News) -- In a case report published in the June 23 issue of the New England Journal of Medicine, dual antimicrobial therapy failure is described in the treatment of gonorrhea.

Helen Fifer, B.M.B.S., from Public Health England in London, and colleagues describe treatment failure with dual therapy in a heterosexual man with gonorrhea.

The authors note that Neisseria gonorrhoeae was detected in a urine specimen and pharyngeal swab, and in a culture of a urethral specimen. Based on testing with the disk-diffusion method, the N. gonorrhoeae strain was resistant to cefuroxime, ciprofloxacin, and tetracycline. The patient was treated with one intramuscular dose of ceftriaxone plus oral azithromycin; on day 15, a urine specimen was negative but a pharyngeal swab remained positive for N. gonorrhoeae. After repeat positive tests on days 79 and 98, the patient received a repeat dose of ceftriaxone and azithromycin; at the test of cure on day 112, the pharyngeal specimen was negative. In antimicrobial susceptibility testing, the strain was found to be resistant to ceftriaxone, azithromycin, cefixime, cefotaxime, penicillin, tetracycline, and ciprofloxacin, but was susceptible to spectinomycin.

"The patient was considered to have treatment failure because the post-treatment isolate was resistant to ceftriaxone and azithromycin, all specimens contained resistance determinants and identical sequence types, and reinfection was deemed to be unlikely," the authors write. "The treatment failure reflected difficulties in treating pharyngeal gonorrhea as compared with urogenital gonorrhea."

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Medicaid Expansion Ups Preemptive Listing for Kidney Transplant

Medicaid Expansion Ups Preemptive Listing for Kidney Transplant

From pre- to post-expansion period, 59 percent relative increase in Medicaid-covered preemptive listings

BCG Vaccine Tied to Reduced Hyperglycemia in Type 1 Diabetes

BCG Vaccine Tied to Reduced Hyperglycemia in Type ...

Systemic shift in glucose metabolism from oxidative phosphorylation to aerobic glycolysis

Many Physicians Not Prepared for End-of-Life Talks With Patients

Many Physicians Not Prepared for End-of-Life Talks With ...

Additional training, reimbursement may foster these critical conversations, authors say

is free, fast, and customized just for you!




Already a member?

Sign In Now »